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ORIGINAL ARTICLE
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Abstract
Purpose Frailty is the body’s failure to return to homeostasis after every day or acute stressful events, causing adverse outcomes.
To study its dynamics in kidney transplant recipients (KTR), we determined whether the degree of frailty and its domains are
affected by kidney transplantation (KT).
Methods Between 2015 and 2017, 176KTRwere included. Frailty scoresweremeasured using theGroningen Frailty Indicator (GFI),
assessed preoperatively and during follow-up. Transitions in frailty state and changes in the individual domains were determined.
Results Mean age (±SD)was 51.8 (± 14.1) years, and 63.1% ofKTRwere male. Thirty patients were considered frail (GFI ≥ 4) at
baseline. After a mean follow-up of 22.8 ± 8.3 months, 34 non-frail patients (19.3%) became frail, 125 patients (71.0%) remained
the same, and 17 frail patients (9.7%) became non-frail (GFI < 4). In the domain psychosocial functioning, 28.4% of the patients
had an increase in GFI score after follow-up. Patients who scored a point in the domain cognition at baseline had a greater chance
of becoming frail (OR 4.38, 95% CI 0.59–32.24).
Conclusion In conclusion, almost one-fifth of non-frail KTR transitioned to a frail state after their transplantation. These results
could be used to predict the impact of KT on frailty course and help with implementing prehabilitation for patients at risk.
Keywords Frailty . Kidney transplantation . Cognition .Mental health
Introduction
Frailty is a frequently occurring physiological condition in
today’s aging population. It is the result of aging-associated
decline in physical, cognitive, physiological, and immune re-
serves which leads to a diminished ability to cope with every
day or acute stressors [1–3]. Fried et al. [4] have defined frailty
as meeting at least three out of five of the following criteria:
unintentional loss of weight, low physical activity, exhaustion,
low grip strength, and reduced walking speed. An increased
inflammatory state, including elevated levels of interleukin 6
and C-reactive protein, has also been reported in frail patients
[5]. Next to these physical aspects, limitations in cognitive
functioning are an important domain of frailty resulting in
unfavorable health outcomes [3].
Preoperatively, approximately one-fifth of kidney transplant
recipients (KTR) are considered frail [6]. Frailty in this particular
group of patients is associated with an increased risk of immu-
nosuppression intolerance, delayed graft function, and long-term
mortality [7–9]. Measuring frailty therefore might aid physicians
in the decision to take precautionary measures.
Currently, there are multiple ways to measure frailty [10].
In our center, the Groningen Frailty Indicator (GFI) is used to
determine whether a patient is frail or not. The GFI is a multi-
domain questionnaire focusing not only on the physical aspect
of the patient but also on cognitive and psychosocial domains,
which is in contrast to many other frailty indicators [11–14]. It
consists of 15 items, involving physical, cognitive, psycholog-
ical, and social aspects of frailty. A GFI ≥ 4 has previously
been demonstrated to be a reliable cut-off value for consider-
ing a patient to be frail [15–18]. Unlike other frailty instru-
ments, the GFI proved to be both time and cost efficient, given
Electronic supplementary material The online version of this article
(https://doi.org/10.1007/s00423-020-01936-6) contains supplementary
material, which is available to authorized users.
* Robert A. Pol
pol.chirurgie@gmail.com
1 Department of Surgery, Division of Vascular and Transplantation
Surgery, University Medical Centre Groningen, P.O. Box 30 001,
9700 RB Groningen, The Netherlands
2 Department of Anaesthesiology, University Medical Centre
Groningen, Groningen, The Netherlands
3 Department of Internal Medicine, Division of Nephrology,
University Medical Centre Groningen, Groningen, the Netherlands
https://doi.org/10.1007/s00423-020-01936-6
Langenbeck's Archives of Surgery (2020) 405:843–850
/ Published online: 20 July 2020
the short time required to complete the test while covering the
most important aspects of frailty [19–21].
Current research is mainly focused on the effect of frailty
on kidney transplantation (KT) outcomes [7, 9, 16]. Frailty is
dynamic, and intervention such as a KT will most likely have
an effect on the degree of frailty [22]. Determining changes in
frailty is important to gain insight into the course of frailty
after surgery and the individual domains that define these
changes. By identifying which domains contribute most to a
transition in frailty state, an opportunity to build an individu-
alized frailty prevention program is created. The primary aim
of this study was to determine transitions in frailty states after
KT over a period of 1 to 3 years. Our secondary aim was to
assess which domains and/or patient characteristics contribut-
ed most to these transitions.
Material and methods
Study design
This study was part of a previously published cohort on frailty
in KTR at the University Medical Center Groningen
(UMCG), the Netherlands [16]. Two hundred and thirty-
three patients were prospectively included during the period
of 2015 to 2017. In all patients, the degree of frailty by means
of the GFI was measured at admission to the ward prior to
kidney transplantation. To determine a transition in frailty
state and the individual frailty domains, the questionnaire
was obtained a second time by contacting all patients by tele-
phone. In the event that patients were unwilling to discuss this
by phone, the questionnaire was sent by conventional mail. A
total of 7 patients died during follow-up, and 50 patients were
unwilling to participate. One hundred and seventy-six patients
(76%) completed the GFI during follow-up and were included
in this study. Due to the descriptive character of this study, our
institution’s Medical Ethics Committee granted dispensation
for the Dutch law regarding patient-based medical research
(WMO) obligation (registration no METc2018/050). Patient
data were processed and electronically stored according to the
declaration of Helsinki - Ethical principles for medical re-
search involving human subjects.
Frailty score and outcome measures
The GFI consists of 15 questions that cover eight separate
domains of functioning: mobility, visual functioning, auditory
functioning, nutritional status, comorbidity, cognition, psy-
chosocial functioning, and physical fitness. The GFI questions
were answered by the patient with the support of a specially
trained nurse. The GFI score was calculated (range 0–15), and
patients were considered frail if the outcome resulted in a
score ≥ 4 [23] (Supplemental Table S1). The preoperative
score was referred to as the index measurement, and the mea-
surement obtained at follow-up was named the follow-up
measurement throughout this study.
The primary outcome measure of this study was the transi-
tion in frailty state after kidney transplantation. Patients were
stratified into three cohorts consisting of 1 year (maximum
12 months), 2 years (minimum 13 to maximum 24), and
3 years (minimum 25 to maximum 36 months) between index
and follow-up measurement. For each patient, it was calculat-
ed whether there was no transition in frailty state, a transition
from non-frail to frail, or a transition from frail to non-frail
after kidney transplantation.
Secondary outcome measures were changes within the in-
dividual GFI domains. In addition, if a transition had occurred,
we determined which variables were most strongly associated
with the transition in frailty state.
Patient data
Collected data included age (years); sex (male/female); type of
kidney donor (living/deceased); type of dialysis prior to trans-
plantation (hemodialysis/peritoneal dialysis/hemodialysis and
hemodialysis/pre-emptive); duration of dialysis (months); body
mass index (BMI; body mass (kg)/height (m)2); hypertension
(y/n); comorbidities; retransplantation (y/n); length of hospital
stay (days); first warm ischemia time (minutes); cold ischemia
time (minutes); second warm ischemia time (minutes); delayed
graft function (DGF) (y/n) defined as recipients receiving he-
modialysis within the first 7 days after transplantation; inten-
sive care admission (y/n); readmission within 30 days of KT
(y/n); time between KT and follow-up (months); admission
between KT and follow-up (y/n); additional surgical proce-
dures between KT and follow-up (y/n); paired exchange
(y/n); and acute rejection (y/n). Comorbidities were assessed
using the Charlson Comorbidity Index. The Charlson
Comorbidity Index is a weighted score (0–24), which predicts
the 1-year mortality of a patient based on the coexisting med-
ical conditions and age [24]. DGF as well as functional DGF
was measured in our cohort. Functional DGF is a more suitable
way to measure DGF in living donation transplants. We will
refer to DGF in the rest of this paper. Acute rejections and
diagnostics were in accordance with the Banff Classification
of Renal Allograft Pathology reference guide [25].
Statistical analysis
For the statistical analysis, the Statistical Package for the
Social Sciences (IBM SPSS Statistics for Windows, version
23.0. IBM Corp., Armonk, NY, USA) was used. Categorical
variables are presented as numbers and percentages.
Continuous variables are presented as mean ± standard devi-
ation (SD) for normally distributed variables and as median ±
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interquartile range (IQR) for skewed variables. Distribution
was assessed with the help of a Q-Q plot and a histogram.
Differences between continuous variables were tested
with an ANOVA test in case of a normal distribution, and
the Mann-Whitney U test for a skewed distribution.
Differences between categorical variables were assessed
using the chi-square test. We analyzed the correlation be-
tween transition in frailty state and the before mentioned
patient characteristics. We then performed a multivariable
analysis using cox regression with non-frail to frail and frail
to non-frail as dependent variables. Gender, comorbidities,
duration of dialysis, type of kidney donor, and acute rejec-
tion were the independent variables in this analysis. These
variables were selected based on literature. We also per-
formed a logistic regression with baseline domain measure-
ments as covariates and transition from a non-frail to a frail
state as independent. Outcome was adjusted for gender, co-
morbidities, kidney transplantation type, duration of dialysis,
and acute rejection. A p value ≤ 0.05 was considered to in-
dicate statistical significance. Estimates of the effects were
reported with corresponding 95% confidence intervals.
Results
Baseline
Baseline characteristics are presented in Table 1. Mean age
of patients was 51.8 ± 14.1 years, of which 63.1% were
male. Mean BMI was 26.0 ± 4.3 kg/m2. One hundred and
four patients (59.1%) were dialysis dependent prior to trans-
plantation and 83% of grafts came from living donors. The
mean dialysis duration was 16.7 ± 21.6 months. Twenty-five
(14.2%) patients underwent a retransplantation at the time of
inclusion. Twelve (6.8%) patients had an acute rejection af-
ter kidney transplantation. Mean follow-up time was 22.8 ±
8.3 months. Eighty-two patients (46.6%) were readmitted to
the hospital at least once during follow-up of this study.
Transition in frailty state
In total, 34 non-frail patients (19.3%) became frail,
125 patients (71.0%) maintained their baseline frailty
status, and 17 frail patients (9.7%) became non-frail
during follow-up. Twelve non-frail patients (24.0%)
after 1 year (N = 50), 11 non-frail patients (17.7%)
after 2 years (n = 62), and 11 non-frail patients
(19 .0%) a f t e r 3 yea r s (n = 64 ) became f r a i l .
Furthermore, 5 frail patients (10.0%) after 1 year (N =
50), 6 frail patients (9.7%) after 2 years (n = 62), and 6
frail patients (8.6%) after 3 years (n = 64) became non-
frail (Table 2; Fig. 1).
Association between patient characteristics and
frailty state
In Table 3, the patient characteristics associated with different
transitions in frailty state are shown. Non-frail patients who
transitioned to frail were older (55.3 ± 12.7) than frail patients
who transitioned to non-frail (51.7 ± 15.6). However, this did
Table 1 Baseline characteristics
Parameter Number (%), mean ± SDa
or median with IQRb
Number of patients 176 (100%)









Peritoneal dialysis 29 (16.5%)
Hemodialysis and peritoneal dialysis 2 (1.1%)
Pre-emptive 72 (40.9%)
Duration dialysis (months) 16.7 ± 21.6
BMIc (kg/m2) 26.0 ± 4.3
Hypertension 98 (55.7%)
Comorbiditiesd 3.7 ± 1.6
Retransplantation 25 (14.2%)
Paired exchange 14 (8%)
Length of stay (days) 10.1 ± 5.6
First warm ischemia time (minutes)
Living 3 (3–4)
Deceased 9 (0–16)
Cold ischemia time (minutes) 162 (150–225)
Second warm ischemia time (minutes) 39.0 ± 11.1
Delayed graft function 19 (10.8%)
Acute rejection 12 (6.8%)
Intensive care unit admission 11 (6.3%)
Readmission within 30 days of KTe 20 (11.4%)
Time between KT and follow-up (months) 22.8 ± 8.3
Readmission during follow-up 82 (46.6%)
Redo surgery during follow-up 44 (25.0%)
a Standard deviation
b Interquartile range
c Body mass index
dAccording to the Charlson Comorbidity Index, a weighted index which
predicts the 1-year mortality by measuring the burden of comorbidities
(range from 0 to 19)
e Kidney transplantation
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not reach statistical significance. There was a significant asso-
ciation between paired exchange and transition in frailty state
(p = 0.035). After multivariable cox regression analysis, no
significant associations were found in the risk of transitioning
to another frailty state (Table 4).
Change per domain
The changes in GFI score per domain are shown in Fig. 2 and
Supplemental Table S2. In the domains cognition,
psychosocial, and physical fitness, 18.8%, 28.4%, and
13.1%, respectively, of the patients showed an increase in
GFI score. In the domain nutrition, 10% of the patients
showed an increase in GFI score in the 1-year follow-up
group. In the 2-year follow-up group and the 3-year follow-
up group, 1.6% of patients showed an increase in GFI. In the
domainsmobility and nutrition, 94.9% and 90.3%, respective-
ly, of patients had no change in GFI score.
Association between baseline domain score and the
transition from a non-frail to a frail state
In Table 5, the associations between baseline domain
score and becoming frail are shown. Patients who
scored a point in the domain cognition at baseline had
a greater chance of becoming frail (OR 4.38, 95% CI
0.59–32.24). Patients who scored a point in the domain
comorbidity at baseline had a greater chance of becom-
ing frail (OR 1.61, 95% CI 0.35–7.51).
Discussion
This study shows the dynamic course of frailty after KT dur-
ing the first 3 years of follow-up, wherein almost one-fifth of
non-frail patients became frail. The frailty domains cognition
and psychosocial functioning seem to be the main contributors
to this transition. Though there were transitions in frailty state,
there was no significant association with outcomes such as
delayed graft function or the number of hospital readmissions.
Our results highlight the importance and advantage of in-
cluding a broad range of domains when measuring frailty.
Frailty is multifactorial, and it is necessary to be aware of all
the factors that can lead to an increase in frailty to focus on
mitigation efforts. Even if a patient is not considered frail, the
individual components of frailty could lead to adverse out-
comes [10, 26]. The GFI provides a holistic perspective of
frailty, including both physical and psychological components
as subgroups, which are often missing in other frailty tools,
making it more versatile [23].
In our study, a positive baseline cognition score was asso-
ciated with a 4 times greater chance of becoming frail. This
shows the importance of customized intervention, such as
prehabilitation, to avoid further decline. The domain psycho-
social functioning also contributed to a transition from a non-
frail to frail state. However, this was not shown to be signif-
icant in the logistic regression. At baseline, patients are not
struggling psychosocially, but rather that they face problems
after kidney transplantation.
Until now, studies have mainly looked at the relationship
between depressive symptoms, frailty, and kidney transplan-
tation. It was found that having depressive symptoms led to an
increased risk of becoming frail after KT [26, 27]. Likewise,
cognitive function has only been studied as a component sep-
arate from frailty in the kidney transplant population. Recent
research showed that frail patients, according to Fried physical
frailty phenotype, have an increased cognitive performance
(Modified Mini-Mental State Investigation) in the short term
following KT but show declines in cognition in the long term
[28]. Based on these data, psychosocial and cognitive factors
are apparently of little known influence but have a significant
impact on frailty and hence deserve extra attention. It is




Years of follow-up Transition in frailty state
From To
Non-frail Frail
One Non-frail 29 (58.0%) 12 (24.0%)
Frail 5 (10.0%) 4 (8.0%)
Two Non-frail 39 (62.9%) 11 (17.7%)
Frail 6 (9.7%) 6 (9.7%)
Three Non-frail 44 (67.2%) 11 (19.0%)
Frail 6 (8.6%) 3 (5.2%)
Total Non-frail 112 (63.6%) 34 (19.3%)
Frail 17 (9.7%) 13 (7.4%)
aAccording to the Groningen Frailty Indicator cut-off of ≥4
Fig. 1 Transition in frailty state during follow-up
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therefore striking that among transplantation health care pro-
fessionals only 2.2% believe that psychosocial status is of
importance when defining frailty [29]. Additionally, in our
center, no program exists to support the psychosocial and
cognitive wellbeing of KT candidates. A proactive and pre-
ventative measurement should be implemented to combat the
negative impact of this domain and increase awareness.
A pilot focusing on prehabilitation among KTR suggested
that significant improvement in physical exercise occurs when
a preventative program, consisting of physical therapy and at-
home exercises, is implemented [30]. Furthermore, cognitive
training and exercise training have been shown to possibly
prevent cognitive decline in hemodialysis patients [31].
Ultimately, creating a patient-tailored post-surgical program
Table 3 Patient characteristics associated with a transition in frailty state
Non-frail to frail No change Frail to non-frail P valuea
N = 34 N = 125 N = 17
Age (years) 55.3 ± 12.7 50.9 ± 14.3 51.7 ± 15.6 0.227
Sex
Male 22 (64.7%) 80 (64.0%) 9 (52.9%) 0.659
Female 12 (35.3%) 45 (36.0%) 8 (47.1%)
Type of kidney donor
Deceased 7 (20.6%) 22 (17.6%) 1 (5.9%) 0.401
Living 27 (79.4%) 103 (82.4%) 16 (94.1%)
Type of dialysis
Pre-emptive 15 (44.1%) 48 (38.4%) 9 (52.9%) 0.629
Hemodialysis 15 (44.1%) 53 (42.4%) 5 (29.4%)
Peritoneal dialysis 3 (8.8%) 23 (18.4%) 3 (17.6%)
Hemodialysis and peritoneal dialysis 1 (2.9%) 1 (0.8%) 0 (0.0%)
Duration of dialysis (months) 21.4 ± 25.9 15.7 ± 20.1 14.81 ± 23.3 0.366
BMIb (kg/m2) 25.9 ± 3.2 26.0 ± 4.5 25.9 ± 4.7 0.978
Hypertension 19 (55.9%) 68 (54.4%) 12 (70.6%) 0.450
Comorbiditiesc 3.9 ± 1.7 3.5 ± 1.6 4.1 ± 1.8 0.282
Retransplantation 3 (8.8%) 19 (15.3%) 3 (17.6%) 0.579
Paired exchange 0 (0.0%) 13 (10.4%) 1 (5.9%) 0.035
Length of stay 10.2 ± 4.1 10.1 ± 6.2 9.7 ± 5.6 0.180
First warm ischemia time (minutes) 3 (2–4) 3 (2–4) 3 (3–4) 0.710
Cold ischemia time (minutes) 162.5 (153.0–302.0) 162.0 (148.5–202.0) 160.0 (151.5–188.0) 0.964
Second warm ischemia time (minutes) 39.2 ± 10.7 38.7 ± 11.0 40.8 ± 12.9 0.771
Delayed graft function 5 (14.7%) 14 (11.2%) 0 (0.0%) 0.270
Acute rejection 1 (2.9%) 11 (8.8%) 0 (0.0%) 0.127
Intensive care unit admission 2 (5.9%) 6 (4.8%) 3 (17.6%) 0.121
Readmission within 30 days of KTd 3 (8.8%) 14 (11.2%) 3 (17.6%) 0.642
Time between KT and follow-up (months) 22.7 ± 8.7 23.0 ± 8.1 22.4 ± 7.9 0.950
Readmission between KT and follow-up 16 (47.1%) 57 (45.6%) 9 (52.9%) 0.849
Surgery between KT and follow-up 8 (23.5%) 32 (25.6%) 4 (23.5%) 0.959
aP values ≤ 0.05 were considered statistically significant
b Body mass index
cAccording to the Charlson Comorbidity Index, a weighted index which predicts the 1-year mortality by measuring the burden of comorbidities (range
from 0 to 19)
d Kidney transplantation
Table 4 Cox regression analysis
of factors associated with
transition in frailty state
Variable Non-frail to frail (n = 34) P value Frail to non-frail (n = 17) P valuea
Hazard ratio (95% CI) Hazard ratio (95% CI)
Gender (female) 0.94 (0.07–3.90) 0.53
Comorbidities (≥ 5 points)b 0.88 (0.39–1.97) 0.75 1.86 (0.67–5.12) 0.23
Duration dialysis (≥ 1 year) 1.32 (0.62–2.81) 0.46 1.40 (0.50–3.91) 0.52
Kidney transplantation type 1.21 (0.48–3.04) 0.69 5.64 (0.65–49.20) 0.12
Acute rejection 0.53 (0.72–3.90) 0.53
aP values ≤ 0.05 were considered statistically significant
b According to the Charlson Comorbidity Index, a weighted index that predicts 1-year mortality by measuring the
burden of comorbidities (range 0–19)
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including psychosocial aspects may decrease frailty. This in
turn may improve the overall health and wellbeing of the
patient and reduce the burden on the healthcare system in
the long run. This could have positive financial and capacity
effects on a healthcare system that is already under pressure.
Prevention and battling against decline in the cognitive and
mental health of KTR should become a standard part of trans-
plant care.
Prior studies have shown that there are numerous factors
which contribute to becoming frail. In this study, we found
that patients who transitioned from a non-frail state to a frail
state were older than patients who transitioned from a frail
state to a non-frail state. When people are older at baseline,
the likelihood of being/becoming frail increases with the cor-
responding risk of becoming more frail while aging in general
[1, 22, 32]. All patients have end-stage renal disease (ESRD)
and the majority requires dialysis, which in itself is associated
with an increased risk of being frail [33]. More than one-third
of patients with ESRD is frail [34]. Patients with advanced
chronic kidney disease often have a low energy intake and
are less active than healthy controls. Additionally, there is an
increased inflammatory state caused by elevated levels of pro-
inflammatory cytokines in chronic kidney disease [35]. The
frailty trajectory among this group of patients is, however,
extremely variable with almost the same number of patients
improving as deteriorating in frailty score [36]. In the case of
kidney transplantation, patients undergo a major surgical pro-
cedure associated with a disruption of the vital homeostasis
from which the body has to recover. Furthermore, the body
has to adapt to the new immunosuppressive drug regimen.
These factors increase the risk for a kidney transplant recipient
to become more frail over time, compared with community-
dwelling older adults who do not endure these changes.
Almost half of the patients which transitioned from a non-
frail to a frail state were pre-emptively transplanted. One
would expect pre-emptive patients to be less at risk of becom-
ing frail, given that dialysis can have a great impact on frailty
[33]. Prior to transplantation, many pre-emptive patients do
not feel ill, though they are living with end-stage kidney dis-
ease. After receiving a transplant, they are faced with new
problems like infections, complications, stress, and sometimes
guilt, all adding to the risk of becoming frail or creating a
sense of vulnerability which negatively affects psychosocial
and cognitive wellbeing. In contrast, dialysis patients often
already experience these issues before the transplantation.
Post-transplantation, they do not experience major changes
or improve in psychosocial state now that they have a func-
tioning kidney [37]. These changes and effects are currently
underexposed in the majority of the kidney transplant pro-
grams, including ours. More attention is necessary, including
the implementation of a possible intervention.
Interestingly, a part of our population of KTR seemed to
improve in frailty (frail to non-frail state) during follow-up.
Despite the enormous impact that a KT has on the physical
and cognitive reserves of a recipient, the health benefit com-
pared with dialysis or end-stage renal disease is extensive.
Herein lies the crux, since a proper patient selection can play
an important role in the expected outcome. Which patient will
have maximum benefit from a transplant and which will sub-
sequently be hindered by an increase in frailty causing him or
her to no longer function at the pre-transplant level? These
issues are difficult to answer but must continue to receive
attention in view of the increasing aging of the population.
Table 5 The effect of the individual frailty domains at baseline on the
transition from a non-frail to a frail state
Frailty domain Non-frail to frail (n = 34)

































aP values ≤0.05 were considered statistically significant
ΩOutcomes adjusted for gender, comorbidities, kidney transplantation






















































Fig. 2 Patients with an increase inGFI score during FU, per domain. GFI,
Groningen Frailty Indicator; FU, follow-up
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This study has some limitations that need to be addressed.
First, contacting the patient by phone creates a risk of bias.
There is a risk that patients do not give all the correct infor-
mation because an immediate response is required and face to
face contact is missing. Also, patients may feel ashamed to
report psychological and physical problems or restrictions. To
minimize this risk, patients were given sufficient time to think
about their answers and if they were not willing to give a
response by phone, they received the questionnaire by mail
and were offered a follow-up telephone consultation. Our re-
sponse rate, using this approach, was 75.5% which is in ac-
cordance with other survey studies and resulted in a reliable
selection to perform our analyses [38–41]. Second, the GFI is
a self-reported questionnaire. Because of differing personali-
ties, pain thresholds, and several coping strategies, a variation
in reporting can occur, leading to an under- or overestimation.
However, we focused on a transition in frailty within the in-
dividual and not on a static frailty measurement. Third, the
GFI has not been used as an evaluative measurement instru-
ment until now, only as a screening instrument. The GFI is a
widely used, validated screening instrument among various
patient categories and can, by its compact and simple design,
be filled in by the patient in a relatively short amount of time
while coveringmany aspects of frailty. Fourth, 25 patients had
undergone a retransplantation during follow-up which could
have clouded the effect of KT on frailty transition. However,
the degree of transition in this group was comparable to the
entire cohort. The domain psychosocial functioning contribut-
ed most to this increase in the retransplantation group. Fifth,
measuring frailty at fixed time points and measurements dur-
ing acute events would have provided a more detailed analysis
of transitions in frailty. However, we believe that this study
still accurately represents transitions in frailty state that occur
during follow-up.
Conclusion
In conclusion, almost one-fifth of the non-frail kidney
transplant patients transitioned to a frail state during the
follow-up period of 1 to 3 years after transplantation.
Cognitive functioning and psychosocial wellbeing were
particularly affected and thereby contributed the most to
a transition in becoming frail. Prevention and battling
against the decline of the cognitive and mental health
of KTR should become a standard part of transplant
care. By preoperatively identifying patients at risk of
becoming more frail after transplantation, health care
providers might be given a tool to decide which specific
prehabilitation program and post-surgical therapy could
be most beneficial in improving long-term patient and
graft outcome.
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